Drug Discovery

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (27-31 July 2026) 

News round-up for 27-31 July by Megan Thomas, Content Team at DDW.  This week’s news roundup centres around investment, innovation and strategic growth, which have dominated this week’s headlines. Across the drug discovery sector, companies have secured funding, expanded R&D capabilities and accelerated the adoption of AI-driven… Read More

#News

#Cardiomyopathy #Drug development #Drug discovery #FDA #HAYA Therapeutics #nHCM #RNA therapy #Symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM) #US Food and Drug Administration (FDA)

Treatment underway for nonobstructive hypertrophic cardiomyopathy 

The US Food and Drug Administration (FDA) has granted Fast Track Designation for HAYA Therapeutics’ HTX-001 for the treatment of symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM).   The first-in-class investigational long non-coding RNA (lncRNA)-targeting therapy is in a Phase Ia/b trial, with the first cohort dosed this past May.  HTX-001 is a… Read More

#News

#3D deep learning imaging #Deep learning #Drug discovery #Financing #Imaging #Qureight #Series B financing

Qureight closes $20 million Series B financing 

Cambridge data analytics company Qureight has raised $20 million in a Series B financing, led by Molten Ventures, which will support expansion of the Company’s 3D deep learning imaging portfolio, alongside commercial expansion to address demand across key new therapeutic markets for lung and heart diseases.  Existing investors Hargreave Hale… Read More

#News

#DDII #DDIIDigitalForum #DDIIeventseries #Drug discovery #Drug discovery events

Drug Discovery Innovators & Investors Digital Forum announces speaker lineup

We are pleased to announce the preliminary speaker lineup for the Drug Discovery Innovators & Investors (DDII) Digital Forum, taking place 30 September 2026. Supported by DDW, the forum brings together senior leaders from biotech, pharma, academia, and investment to explore the opportunities and challenges shaping early-stage drug discovery. Running… Read More

#News

Neurons in the brain
#Drug discovery #Gene therapy #Neurology #Neuroscience #Webinar

Learn about neuroscience drug discovery in this free webinar

Hosted by Drug Discovery World and supported by BioIVT, this webinar examines the advances, challenges and opportunities that exist in neuroscience drug discovery and development. You will hear from a number of experts who will discuss how both technology and scientific approaches are helping enable the development of… Read More

#News

Informatics
#AI / data analytics / healthtech / informatics #Drug discovery #Webinar

Webinar: Discover faster, more informed scientific decision-making

In drug discovery, valuable scientific insights are often scattered across spreadsheets, slide decks and email threads. Chemistry teams spend hours preparing for update meetings, chasing CRO progress and digging into the data to find out what has been done before. When hypotheses and learnings only live in slides or individual… Read More

#News

#Biotechnology #Cancer research #Drug discovery #Tumours

This week in Drug Discovery (20-24 July 2026) 

News round-up for 20-24 July by Megan Thomas, Content Team at DDW.  This week’s news roundup highlights the latest advances in cancer research and treatment, from promising clinical trial updates to discoveries that could improve the body’s immune response to tumours. The top stories include progress in… Read More

#News

Human kidneys
#Biotechnology #Clinical stage biotechnology #Drug discovery #Funding #Rege Nephro #Regenerative Medicine

Rege Nephro secures US$10.6m for ADPKD and beyond

Rege Nephro, a Japanese clinical-stage biotechnology company focused on iPS cell-based kidney regenerative medicine and drug discovery, has closed a financing round totalling approximately US$10.6 million. Through the issuance of Japan-Keep It Simple Security (J-KISS) share acquisition rights, proceeds are expected to support commercialisation activities for RN-014, the company’s lead… Read More

#News

Neuroscience concept
#Drug discovery #Gene therapy #Neurology #Neuroscience #Webinar

Register now: The advances in neuroscience drug discovery

Hosted by Drug Discovery World and supported by BioIVT, this webinar examines the advances, challenges and opportunities that exist in neuroscience drug discovery and development. You will hear from a number of experts who will discuss how both technology and scientific approaches are helping enable the development of… Read More

#News

#Biology #Clinical trials #Drug discovery #New approach methodologies (NAMs)

A turning point for human-based drug discovery 

Daniel Delubac, Chief Executive Officer at iOrganBio, looks at how technologies that mimic human behaviour can improve drug discovery efforts past animal models.  The US is signalling a decisive shift toward human-based drug discovery. In March, the National Institutes of Health… Read More

#Exclusive Content

Vaccine vial and syringe
#Drug discovery #eBook #Immunology / Virology & Vaccines

eBook: The latest developments in vaccines and virology 

The 2025 Global Vaccines Market Report from the World Health Organization (WHO) reports a total financial value of $66 billion in 2024, though this is predicted to grow to $227.89 billion by 2034 due to the rising prevalence of infectious diseases and increasing demand for immunisation programmes. Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Webinar

Watch on-demand: Real-time chemistry coordination for modern drug discovery

In drug discovery, valuable scientific insights are often scattered across spreadsheets, slide decks and email threads. Chemistry teams spend hours preparing for update meetings, chasing CRO progress and digging into the data to find out what has been done before. When hypotheses and learnings only live in slides or individual… Read More

#News

International Space Station (ISS)
#Drug discovery #ETH Zurich #Switzerland

Swiss institutes pioneer microgravity drug discovery research

As the world celebrates International Moon Day (20 July), Switzerland is championing the opportunities space exploration opens for life sciences.  Leading international players including Starlab Space and Axiom Space have selected Switzerland as their European hub for the next generation of commercial orbital laboratories, supporting R&D in… Read More

#Business & Investment #News #Trending News

MRI of the brain
#Drug discovery #epilepsy #Gene therapy

EpilepsyGTx partners with ClearPoint for gene therapy delivery  

Biotechnology company EpilepsyGTx has partnered with ClearPoint Neuro on a project that will support the targeted delivery of the biotech’s gene therapy candidate, EPY201, for focal refractory epilepsy (FRE).  The agreement will see EpilepsyGTx use the ClearPoint SmartFlow Cannula and the ClearPoint Neuro Navigation system to administer EPY201 in its upcoming first-in-human Phase I/IIa clinical trial for FRE.  ClearPoint’s MRI-guided stereotactic… Read More

#News

#Biomedical research #Biotechnology #Drug discovery #Heart disease #mRNA-based vaccines

This week in Drug Discovery (13 – 17 July) 

News round-up for 13 – 17 July by Bruno Quinney, Content Team at DDW.  This week, a new drug has shown potential to treat heart disease. Elsewhere, Cancer Research UK is leading a global cancer trial.  The top stories:  New drug could treat common heart disease, study… Read More

#News

Heart
#Clinical trial #Drug discovery #Heart disease #The University of Manchester

New drug could treat common heart disease, study shows 

A new drug that reduces heart muscle thickening could represent a new treatment option for heart disease patients, a study says.  The TEMPEST trial, led by researchers at the University of Manchester, tested the drug trientine in 154 adults with hypertrophic cardiomyopathy in a year-long, placebo-controlled study. Read More

#News